JD Health demonstrated strong performance in 2024 with significant revenue growth and expansion in AI and B2C leadership. Despite some increases in expenses and slower direct sales growth, the company's strategic initiatives and robust service revenue highlight a positive outlook.

Company Guidance -

Q4 2025

During the JD Health International 2024 Annual Results Conference Call, the company reported a full-year revenue of RMB58.16 billion, marking an 8.6% year-over-year increase. Excluding the pandemic-related high comparison base from the first quarter, revenue growth in the second to fourth quarters was 13.4% year-over-year. The annual active user count exceeded 183 million, with over 498,000 average daily online consultations. JD Health's direct sales revenue was RMB48.8 billion, a 6.9% increase from the previous year, driven by strong performance in pharmaceuticals. Service revenue for 2024 reached RMB9.36 billion, growing 18.9% year-over-year and comprising 16.1% of total revenue. The company's gross profit margin improved by 17 basis points to 22.9%, and non-IFRS net profit rose by 15.9% to RMB4.8 billion, achieving a margin of 8.2%. JD Health continued to enhance its omnichannel and AI initiatives, maintaining a robust cash position with RMB59.42 billion in reserves by year-end.

Robust Revenue Growth

JD Health achieved a full year revenue of RMB58.16 billion in 2024, up 8.6% year-over-year, with significant growth in pharmaceutical sales and non-pharmaceutical segments.

Expansion of B2C Leadership

The company solidified its B2C leadership by increasing its omnichannel initiatives and leadership in pharmaceuticals, with a focus on imported drugs and innovative treatments.

AI Innovations

JD Health launched Jingyi Qianxun, a large language model, and other AI-powered tools to enhance doctor productivity and user experience, aiming for AI-powered transformation in healthcare.

Increased Service Revenue

Service revenue surpassed RMB9.36 billion for the year, marking an 18.9% increase year-over-year, with significant contributions from platform commissions and advertising revenue.

High-Quality Active User Base

The annual active user count exceeded 183 million, with an average daily online consultation volume of over 498,000, demonstrating strong user engagement.

JD Health International, Inc. (HK:6618) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

HK:6618 Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 30, 2026	2025 (Q4)	0.64 / -	0.741	―	―	―
Aug 14, 2025	2025 (Q2)	1.08 / 0.88	0.708	24.62% (+0.17)	―	―
Mar 06, 2025	2024 (Q4)	0.69 / 0.74	0.199	271.58% (+0.54)	―	―
Aug 15, 2024	2024 (Q2)	0.72 / 0.71	0.534	32.65% (+0.17)	―	―
Mar 20, 2024	2023 (Q4)	0.22 / 0.20	0.272	-26.80% (-0.07)	―	―
Aug 16, 2023	2023 (Q2)	0.11 / 0.53	0.076	600.00% (+0.46)	―	―
Mar 22, 2023	2022 (Q4)	0.34 / 0.27	0.261	4.17% (+0.01)	―	―
Aug 23, 2022	2022 (Q2)	0.23 / 0.08	-0.163	146.67% (+0.24)	―	―
Mar 28, 2022	2021 (Q4)	0.19 / 0.26	-4.649	105.62% (+4.91)	―	―
Aug 24, 2021	2021 (Q2)	0.47 / -0.16	-2.023	91.92% (+1.86)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

HK:6618 Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	HK$55.95	HK$54.85	-1.97%
Mar 06, 2025	HK$38.65	HK$40.80	+5.56%
Aug 15, 2024	HK$20.45	HK$19.82	-3.08%
Mar 20, 2024	HK$32.15	HK$32.05	-0.31%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does JD Health International, Inc. (HK:6618) report earnings?

JD Health International, Inc. (HK:6618) is schdueled to report earning on Mar 30, 2026, TBA (Confirmed).

What is JD Health International, Inc. (HK:6618) earnings time?

JD Health International, Inc. (HK:6618) earnings time is at Mar 30, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of JD Health International, Inc. stock?

The P/E ratio of JD Health International, Inc. is N/A.

What is HK:6618 EPS forecast?

HK:6618 EPS forecast for the fiscal quarter 2025 (Q4) is 0.64.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing